NF-kappaB in pathogenesis and therapy of head and neck cancer
NF-κB 在头颈癌发病机制和治疗中的作用
基本信息
- 批准号:10688908
- 负责人:
- 金额:$ 35.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AlcoholsBiological MarkersCessation of lifeClinicalCytologyCytotoxic agentDefectDeglutitionDiagnosisDiseaseDrug TargetingEarly DiagnosisEarly treatmentFRAP1 geneGene ExpressionGeneticHead and Neck CancerHead and Neck Squamous Cell CarcinomaHuman PapillomavirusImpairmentInvestigationLarynxMalignant NeoplasmsMediator of activation proteinMolecularMulticenter TrialsNF-kappa BNormal tissue morphologyOperative Surgical ProceduresOral cavityPathogenesisPathway interactionsPatientsPharyngeal structurePlayPreventionPrevention approachProgressive DiseaseQuality of lifeRNA interference screenRadiationRecurrenceRecurrent diseaseReporterRoleSignal PathwaySignal TransductionSpeechSquamous EpitheliumTNF geneThe Cancer Genome AtlasTherapeuticVoicechemotherapygenome-wideirradiationmalignant phenotypenotch proteinnovel strategiesresponseside effecttargeted treatmenttherapy resistanttobacco exposuretranscription factor
项目摘要
As part of The Cancer Genome Atlas group characterizing head and neck cancer, we have identified components of the classical and alternative NF-kB, PI3K-mTOR, and Notch pathways as candidate genetic drivers for aberrant NF-kB activation and defects in death signaling.
A multi-center trial targeting IAPs in the classical TNF-NF-kB pathway in combination with re-irradiation continues.
Studies using a genome wide RNAi screen employing NF-kB reporter lines have identified potential drug targets promoting NF-kB activation, under investigation.
作为研究头颈癌的癌症基因组图谱小组的一部分,我们已经确定经典和替代的核因子-kB、PI3K-mTOR和Notch通路的组成部分是导致核因子-kB异常激活和死亡信号缺陷的候选遗传驱动因素。
以经典的肿瘤坏死因子-核因子-kB途径中的IAP为靶点并结合再次照射的多中心试验仍在继续。
使用核因子-kB报告线的全基因组RNAi筛选的研究已经确定了促进核因子-kB激活的潜在药物靶点,正在调查中。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immunohistochemical analysis of NF-κB in human tumor tissue.
人类肿瘤组织中 NF-κB 的免疫组织化学分析。
- DOI:10.1007/978-1-4939-2422-6_28
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Allen,ClintT;VanWaes,Carter
- 通讯作者:VanWaes,Carter
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
- DOI:10.1038/onc.2013.49
- 发表时间:2014-02-27
- 期刊:
- 影响因子:8
- 作者:
- 通讯作者:
CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancer.
- DOI:10.1158/1078-0432.ccr-14-2550
- 发表时间:2015-03-01
- 期刊:
- 影响因子:0
- 作者:Allen CT;Conley B;Sunwoo JB;Van Waes C
- 通讯作者:Van Waes C
Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
- DOI:10.1158/0008-5472.can-17-0642
- 发表时间:2018-08-15
- 期刊:
- 影响因子:11.2
- 作者:Zhang J;Chen T;Yang X;Cheng H;Späth SS;Clavijo PE;Chen J;Silvin C;Issaeva N;Su X;Yarbrough WG;Annunziata CM;Chen Z;Van Waes C
- 通讯作者:Van Waes C
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
- DOI:10.1158/1078-0432.ccr-16-2172
- 发表时间:2017-03-15
- 期刊:
- 影响因子:0
- 作者:Derakhshan A;Chen Z;Van Waes C
- 通讯作者:Van Waes C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARTER VAN WAES其他文献
CARTER VAN WAES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARTER VAN WAES', 18)}}的其他基金
GENE AND IMMUNOTHERAPY OF NEOPLASMS AFFECTING HUMAN COMMUNICATION
影响人类交流的肿瘤基因和免疫治疗
- 批准号:
6289632 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
NF-kappaB in pathogenesis and therapy of head and neck cancer
NF-κB 在头颈癌发病机制和治疗中的作用
- 批准号:
8349616 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
Molecular Therapy Of Neoplasms Affecting Human Communica
影响人类通讯的肿瘤的分子治疗
- 批准号:
6966643 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
NF-kappaB in pathogenesis and therapy of head and neck cancer
NF-κB 在头颈癌发病机制和治疗中的作用
- 批准号:
8745647 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
NF-kappaB in pathogenesis and therapy of head and neck cancer
NF-κB 在头颈癌发病机制和治疗中的作用
- 批准号:
9147422 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
Gene And Immunotherapy Of Neoplasms Affecting Human Comm
影响人类通讯的肿瘤的基因和免疫治疗
- 批准号:
6690276 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
Molecular Therapy Of Neoplasms Affecting Human Communication
影响人类交流的肿瘤的分子治疗
- 批准号:
7593327 - 财政年份:
- 资助金额:
$ 35.93万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 35.93万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 35.93万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 35.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 35.93万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 35.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 35.93万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 35.93万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 35.93万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 35.93万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 35.93万 - 项目类别:
Studentship














{{item.name}}会员




